AU5049098A - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
AU5049098A
AU5049098A AU50490/98A AU5049098A AU5049098A AU 5049098 A AU5049098 A AU 5049098A AU 50490/98 A AU50490/98 A AU 50490/98A AU 5049098 A AU5049098 A AU 5049098A AU 5049098 A AU5049098 A AU 5049098A
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50490/98A
Inventor
Stella Rudkjaer Rasmussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU5049098A publication Critical patent/AU5049098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU50490/98A 1996-11-28 1997-11-26 Pharmaceutical formulation Abandoned AU5049098A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK1359/96 1996-11-28
DK135996 1996-11-28
DK1265/97 1997-11-07
DK126597 1997-11-07
PCT/DK1997/000543 WO1998023270A1 (en) 1996-11-28 1997-11-26 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
AU5049098A true AU5049098A (en) 1998-06-22

Family

ID=26065492

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50490/98A Abandoned AU5049098A (en) 1996-11-28 1997-11-26 Pharmaceutical formulation

Country Status (4)

Country Link
EP (1) EP0959880A1 (en)
JP (1) JP2001504502A (en)
AU (1) AU5049098A (en)
WO (1) WO1998023270A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA989763B (en) * 1997-11-07 1999-05-07 Novo Nordisk As Pharmaceutical composition comprising levormeloxifene in low dose
US7182958B1 (en) 1999-08-03 2007-02-27 Lilly Icos Llc. β-carboline pharmaceutical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
US5563133A (en) * 1995-02-21 1996-10-08 Eli Lilly And Company Hexamethyleneiminyl tachykinin receptor antagonists

Also Published As

Publication number Publication date
EP0959880A1 (en) 1999-12-01
WO1998023270A1 (en) 1998-06-04
JP2001504502A (en) 2001-04-03

Similar Documents

Publication Publication Date Title
AU6995396A (en) Pharmaceutical formulation
AU7572196A (en) Pharmaceutical formulations
AU7499096A (en) Stable freeze-dried pharmaceutical formulation
AU4762797A (en) Pharmaceutical compositions
AU1756897A (en) Avermectin formulation
AU2967597A (en) Pharmaceutical compositions
AU5136998A (en) Medicinal composition
AU6740298A (en) Pharmaceutical composition
AU6973396A (en) Pharmaceutical formulation
AU3777897A (en) Pharmaceutical compositions
AU8107998A (en) Pharmaceutical compositions
AU4330097A (en) Pharmaceutical compounds
AU2531295A (en) Pharmaceutical composition
AU7582696A (en) Pharmaceutical formulation
AU9343098A (en) Pharmaceutical composition
AU3460897A (en) Medicinal compositions
AU4169897A (en) Pharmaceutical compounds
AU1475595A (en) Pharmaceutical preparation
AU7711096A (en) Cisplatinum comprising pharmaceutical
AU4326197A (en) Pharmaceutical compositions
AU4457597A (en) Pharmaceutical compositions
AU2087897A (en) Pharmaceutical compositions
AU5182099A (en) Pharmaceutical formulation
AU4795497A (en) Anthelmintic formulation
AU1427895A (en) Pharmaceutical compositions